CytoTools AG
Description CytoTools AG, together with its subsidiaries, develops therapy forms for wound healing disturbances, urinary tract infections, and cardiovascular diseases. Its lead products include DermaPro in Phase IIb clinical stage for the treatment of venous ulcers, and in Phase III clinical stage for the treatment of diabetic gangrene; and CardioClean in the pre-clinical development phase for treating restenosis and carotid stenosis. The companys other products comprise Utisept, a medicinal product for irrigating the bladder during urinary tract infections; and Peptid, a Phase I clinical stage product for the treatment of burns, as well as research and development stage products, including HMW02ak for treating arteriosclerosis, HMW 02Ac for diagnostic purposes, and LMW 6+ for the treatment of cancer. CytoTools AG was founded in 2000 and is based in Darmstadt, Germany. To view the detailed information, you need to SUBSCRIBE with us. |
 |